JOINT CORP/THE (JYNT)
$16.42
Market is closed - opens on 7 PM, 24 Mar 2023
Market is closed - opens on 7 PM, 24 Mar 2023
Powered by
Performance
| Returns % | |
| 1 month return |  9.89% |
| 3 month return | 10.33% |
| 1 year return |  53.22% |
| 5 year return | 170.89% |
Insights on JOINT CORP/THE
Increasing Revenue
Revenue is up for the last 11 quarters, 12.58M → 27.81M (in $), with an average increase of 7.5% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -205.79K → 547.19K (in $), with an average increase of 66.6% per quarter
Vs OSH
In the last 1 year, Oak Street Health Inc has given 36.1% return, outperforming this stock by 89.3%
Highlights
| Market Capitalization | 244.4M |
| Book Value | $2.23 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | 0.08 |
| PE Ratio | 209.63 |
| PEG Ratio | -0.7 |
| Wall Street Target Price | 27.25 |
Company Financials
| FY22 | Y/Y Change | |
|---|---|---|
Revenue | 101.9M | ↑ 25.52% |
Net Income | 1.2M | ↓ 83.56% |
Net Profit Margin | 1.16% | ↓ 7.66% |
Peers
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $244.4M | 170.89% | 209.63 | 1.16% |
 | Buy | $11.5B | -10.32% | NA | -3.93% |
 | Buy | $72.2B | 157.52% | 13.39 | 9.37% |
 | Hold | $8.7B | -11.48% | NA | -23.56% |
 | Hold | $8.7B | 1.67% | 13.49 | 5.04% |
Analyst Recommendation
Based on 12 Wall street analysts offering stock ratings for JOINT CORP/THE(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 65.96%Current
$16.42
Target
$27.25
Valuation
| Trailing PE | 209.63 |
| Forward PE | 55.87 |
| Price/Book (mrq) | 7.48 |
| Enterprise Value | 249.9M |
| Enterprise Value/Revenue | 2.6 |
| Enterprise Value/Ebitda | 30.0 |
Technicals
| Beta | 1.35 |
| 50 Day MA | 16.73 |
| 200 Day MA | 16.43 |
Institutional Holdings
Bandera Partners LLC
BlackRock Inc
Vanguard Group Inc
Morgan Stanley - Brokerage Accounts
Federated Hermes Inc
State Street Corporation
Company Information
| Organization | JOINT CORP/THE |
| Employees | 359 |
| CEO | Mr. Peter D. Holt |
| Industry | Health Services |
Corporate Announcements
JOINT CORP/THE Earnings
JOINT CORP/THE’s price-to-earnings ratio stands at 209.63
Read More
Discover more
PERIPHAS CAPITAL PARTNR-CL A
+0.04%▲
HAMILTON LANE ALL-CLASS A
--
TCW SPECIAL PURPOSE ACQ-CL A
+0.02%▲
Invesco BulletShares 2022 Corporate Bond ETF
+0.02%▲
GORES TECHNOLOGY PARTNERS-A
Pennsylvania Real Estate Investment Trust
--
SIMON PROPERTY GROUP ACQUI-A
KL ACQUISITION CORP/MO-CLS A
+0.25%▲
GLENFARNE MERGER CORP-A
--
Frequently Asked Questions
What is JOINT CORP/THE share price today?
Can Indians buy JOINT CORP/THE shares?
How can I buy JOINT CORP/THE shares from India?
Can Fractional shares of JOINT CORP/THE be purchased?
What are the documents required to start investing in JOINT CORP/THE stocks?
What are today’s High and Low prices of JOINT CORP/THE?
What are today’s traded volumes of JOINT CORP/THE?
What is today’s market capitalisation of JOINT CORP/THE?
What is the 52 Week High and Low Range of JOINT CORP/THE?
How much percentage JOINT CORP/THE is down from its 52 Week High?
How much percentage JOINT CORP/THE is up from its 52 Week low?
What are the historical returns of JOINT CORP/THE?
Who is the Chief Executive Officer (CEO) of JOINT CORP/THE?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*